Advanced Biomed is trading 10.1% down at $17.06 as the stock retreats following a sharp multi-day rally triggered by a canceled securities offering.
- The recent spike was driven by the company's decision to scrap a planned securities offering, which eased investor concerns regarding share dilution and sparked heavy buying.
- Shares are currently normalizing as momentum cools and traders move to lock in profits after several sessions of extreme gains.